NCT00382096View on ClinicalTrials.gov

Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

1,179

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

June 3, 2008

Study Completion Date

June 3, 2008

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Vildagliptin

DRUG

Metformin

DRUG

Vildagliptin + Metformin

Trial Locations (2)

07936

Novartis Pharmaceuticals, East Hanover

Unknown

Multiple Locations

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY